The trademark application EARLY TAVR was filed by Edwards Lifesciences Corporation, a U.S. corporation (the "Applicant"). Application refused.
The application was filed in English (French was selected as the second language).
Change of name and address of the trademark registration was recorded on February 26, 2023. Requests for conversion of an EUTM application into a national trade mark application of the trademark registration was recorded on November 13, 2023.
The Appeal with reference B R0194/2023-1 was Trade mark application refused according to Article 7(1)(b) EUTMR with decision issued on June 25, 2023 by the EUIPO. The Refusal with reference B 018703057 was Rejected according to Article 7(1)(b) EUTMR with decision issued on November 23, 2022 by the EUIPO.